Contact us

SeqOne S.A.S

SeqOne S.A.S.
C/IRMB - Hopital St Eloi
80 Avenue Augustin Fliche
34090 Montpellier France
Jean-Marc Holder
+33 6 03 24 57 56

FDA approves gene-altering leukemia therapy in US

The FDO today approved a leukemia treatment involving patient genetic modification

The New York times today reported that the FDA had approved the first therapy that involves human genetic modification.   The procedure developed by Novartis to combat leukemia will be the first gene therapy ever to reach the market in the US.  Read the full article here.

Next generation genomic analysis for next generation healthcare